@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-PXB4GFQL-Z
  skos:prefLabel "Serotonin Antagonists"@en, "Antisérotonines"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3TZZ34V-L
  skos:prefLabel "Acide lysergique"@fr, "Lysergic Acid"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-L6HDGFX2-3 .

jvr:-VWR9VF8K-H
  skos:prefLabel "Serotonin Receptor Agonists"@en, "Agonistes des récepteurs de la sérotonine"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-B6H65C4Z-Q
  skos:prefLabel "Hallucinogènes"@fr, "Hallucinogens"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6HDGFX2-3
  mesh:allowableQualifier jvr:-TJHVZCRZ-0, jvr:-BT300B3G-Q, jvr:-L6C0XPHT-4, jvr:-T9HQD7ST-J, jvr:-NFTHND7Q-8, jvr:-HQRFT0C6-B, jvr:-SBNWSM1T-R, jvr:-S0CS1X5R-5, jvr:-W6SQV79N-S, jvr:-D0F21513-5, jvr:-FWD2BGQ0-9, jvr:-R0ZCQ8X6-J, jvr:-M63HSDM7-1, jvr:-G4R176S9-J, jvr:-G30ZJ446-J, jvr:-R3QWLHRG-V, jvr:-CB30NGKB-3, jvr:-NB0XHT3S-N, jvr:-WK5F724J-1, jvr:-XV06LPML-W, jvr:-NHL3D2X0-S, jvr:-Q3979798-W, jvr:-THHNVC7V-3, jvr:-NKM836P1-M, jvr:-H7K65Q8S-Z ;
  skos:hiddenLabel "Tartrate de lysergide"@fr, "Lysergic Acid Diethylamide Tartrate"@en ;
  dc:created "1999-01-01"^^xsd:date ;
  mesh:pharmacologicalAction jvr:-PXB4GFQL-Z, jvr:-VWR9VF8K-H, jvr:-B6H65C4Z-Q ;
  skos:definition "Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood."@en ;
  skos:altLabel "LSD"@en, "LSD"@fr, "LSD-25"@en, "50-37-3 (Lysergic Acid Diethylamide)"@fr, "50-37-3 (Lysergic Acid Diethylamide)"@en, "8NA5SWF92O"@fr, "8NA5SWF92O"@en, "Ergoline-8-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-, (8beta)-"@fr, "Ergoline-8-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-, (8beta)-"@en, "Lysergide"@en ;
  dc:established "1966-01-01"^^xsd:date ;
  skos:prefLabel "Lysergic Acid Diethylamide"@en, "Lysergide"@fr ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D008238> ;
  dc:modified "2016-05-31"^^xsd:date ;
  skos:broader jvr:-Q3TZZ34V-L ;
  a skos:Concept, mesh:Descriptor ;
  skos:inScheme jvr: .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .